Investor Details
| Filer Name: | ACORN CAPITAL ADVISORS, LLC |
|---|---|
| CIK: | 2054410 |
| Period: | 2024-12-31 |
| Filed At: | 2025-02-14 |
| Number of Holdings: | 20 |
| Portfolio Value: | $0.19B |
Acorn Capital Advisors, Llc Top Holdings
| Ticker | Exchange | Security | Shares | Value | % of Portfolio | Position Change | Put/Call |
|---|---|---|---|---|---|---|---|
| CGON | US | CG ONCOLOGY INC | 1,131,501 | $32M | 17.54% | - | - |
| YMAB | US | Y-MABS THERAPEUTICS INC | 2,861,825 | $22M | 12.11% | - | - |
| CADL | US | CANDEL THERAPEUTICS INC | 1,939,644 | $17M | 9.10% | - | - |
| URGN | US | UROGEN PHARMA LTD | 1,516,303 | $16M | 8.73% | - | - |
| PBYI | US | PUMA BIOTECHNOLOGY INC | 2,450,711 | $12M | 6.49% | - | - |
| BCAX | US | BICARA THERAPEUTICS INC | 643,381 | $11M | 6.06% | - | - |
| TERN | US | TERNS PHARMACEUTICALS INC | 1,971,264 | $11M | 5.90% | - | - |
| OKUR | US | ONKURE THERAPEUTICS INC-A | 1,439,674 | $10M | 5.54% | - | - |
| TRVI | US | TREVI THERAPEUTICS INC | 2,001,048 | $8M | 4.46% | - | - |
| TARA | US | PROTARA THERAPEUTIC INC | 1,279,800 | $7M | 3.65% | - | - |
| CYBN | US | CYBIN INC | 734,393 | $6M | 3.50% | - | - |
| CRDF | US | CARDIFF ONCOLOGY INC | 1,442,308 | $6M | 3.38% | - | - |
| XFOR | US | X4 PHARMACEUTICALS INC | 7,310,650 | $5M | 2.90% | - | - |
| MURA | US | MURAL ONCOLOGY PLC | 1,286,079 | $4M | 2.24% | - | - |
| AADI | US | AADI BIOSCIENCE INC | 1,147,052 | $4M | 1.96% | - | - |
| 68404V209 | - | OPTINOSE INC | 422,813 | $3M | 1.53% | - | - |
| QTTB | US | Q32 BIO INC | 803,425 | $3M | 1.49% | - | - |
| ACRV | US | ACRIVON THERAPEUTICS INC | 405,237 | $2M | 1.32% | - | - |
| BCAB | US | BIOATLA INC | 4,032,046 | $2M | 1.29% | - | - |
| VYNE | US | VYNE THERAPEUTICS INC | 456,970 | $2M | 0.83% | - | - |